Apellis Pharmaceuticals I... (APLS)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

33.19

-0.15%

After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13
Revenue	396.59M	75.42M	66.56M	250.65M	-	-	-	-	-	-	-
Cost of Revenue	58.51M	5.64M	5.20M	25.05M	288.02M	127.92M	50.77M	-	-	-	-
Gross Profit	338.08M	69.79M	61.36M	225.60M	-288.02M	-127.92M	-50.77M	-	-	-	-
Operating Income	-517.12M	-594.61M	-536.28M	-213.73M	-288.02M	-127.92M	-50.77M	-27.28M	-46.57M	-11.29M	-4.03M
Interest Income	20.93M	8.91M	418.00K	4.16M	5.11M	2.96M	-	-	-	-	-
Pretax Income	-526.50M	-651.50M	-746.00M	-343.03M	-304.71M	-127.50M	-51.01M	-27.12M	-46.52M	-11.23M	-3.96M
Net Income	-528.63M	-652.17M	-746.35M	-344.87M	-309.82M	-127.50M	-51.01M	-27.12M	-46.52M	-10.79M	-3.96M
Selling & General & Admin	500.81M	277.16M	176.77M	139.40M	67.05M	22.64M	10.46M	4.30M	6.36M	2.91M	1.71M
Research & Development	354.39M	387.24M	420.87M	299.92M	220.97M	105.29M	40.30M	22.98M	13.73M	8.38M	2.32M
Other Expenses	-	-288.00K	1.36M	-501.00K	-175.31K	-110.76K	11.54K	157.71K	6.28K	62.46K	68.00K
Operating Expenses	855.20M	664.40M	597.64M	439.32M	288.02M	127.92M	50.77M	27.28M	20.09M	11.29M	4.03M
Interest Expense	29.58M	32.63M	13.24M	29.94M	5.28M	2.51M	96.92K	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	913.71M	670.03M	602.84M	464.37M	288.02M	127.92M	50.77M	27.28M	20.09M	11.29M	4.03M
Income Tax	2.13M	669.00K	352.00K	1.84M	5.11M	-533.32K	250.61K	-27.28M	-26.54M	-443.34K	-
Shares Outstanding (Basic)	118.68M	106.11M	84.42M	75.16M	62.23M	54.40M	13.87M	18.09M	18.09M	18.09M	18.09M
Shares Outstanding (Diluted)	118.68M	106.11M	84.42M	75.16M	62.23M	54.40M	13.87M	18.09M	18.09M	18.09M	18.09M
EPS (Basic)	-4.45	-6.15	-8.84	-4.59	-4.98	-2.34	-3.68	-1.5	-2.57	-0.6	-0.22
EPS (Diluted)	-4.45	-6.15	-8.84	-4.59	-4.98	-2.34	-3.68	-1.5	-2.57	-0.6	-0.22
EBITDA	-495.21M	-617.39M	-731.27M	-312.23M	-298.83M	-	-50.90M	157.71K	6.40M	-11.29M	-4.02M
Depreciation & Amortization	1.70M	1.49M	1.49M	859.00K	595.45K	127.92M	11.94K	27.28M	52.97M	6.59K	6.26K